Product Information

DESVENLAFAXINE SUCCNT ER 100 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4069 per EA under NDC 68180059306. Its NADAC has been published 484 times since May 17, 2017.

FDA first approved this application on Jun 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DESVENLAFAXINE SUCCNT ER 100 MG

Desvenlafaxine Succinate
$0.4069per EA

Strength

100 mg/1

NDC

68180059306

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204172

FDA Approved

6/29/2015

TE Code

AB

On Market Since

3/1/2017

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has been published 484 times since May 17, 2017, and over the history we have for it it has declined 74.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4069 per EA
All-time high$1.6168 (Jun 14, 2017)
All-time low$0.3558 (Nov 20, 2024)
52-week high$0.4587
52-week low$0.4069
Median price$0.6310
Average price$0.6749
Largest weekly change+25.7% (Jun 19, 2024)
Weeks tracked484
Tracking sinceMay 17, 2017

Price History

1W

-2.5%

1M

-2.5%

3M

-4.6%

6M

-5.8%

1Y

-11.3%

3Y

-19.8%

5Y

-37.6%

All

-74.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DESVENLAFAXINE SUCCNT ER 100 MG?

The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE SUCCNT ER 100 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.4069 per EA (NDC 68180059306), effective Aug 19, 2026.

How has the price of DESVENLAFAXINE SUCCNT ER 100 MG changed over time?

Over the history we have for it, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has declined 74.8%. It has been tracked across 484 weekly CMS publications since May 17, 2017.

What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE SUCCNT ER 100 MG?

Since May 17, 2017, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has ranged from a low of $0.3558 (Nov 20, 2024) to a high of $1.6168 (Jun 14, 2017), with a median of $0.6310 per EA.

Are there cheaper alternatives to DESVENLAFAXINE SUCCNT ER 100 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESVENLAFAXINE SUCCNT ER 100 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures DESVENLAFAXINE SUCCNT ER 100 MG?

DESVENLAFAXINE SUCCNT ER 100 MG (NDC 68180059306) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.